Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1.

NCT05858229 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma
RP1

Interventions

DRUG: RP1

Sponsor

Sherrif Ibrahim